CD4 and hepatocellular carcinoma: In the first part of our study, we aimed to identify to date unknown inhibitory molecules on CD4 and CD8 T lymphocytes, which are upregulated during HCC development using microarray analysis (see “Experimental setup” in Supplementary Figure S1).